| Market Capitalization (Millions $) |
8 |
| Shares
Outstanding (Millions) |
17 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
32 |
| Net Income (TTM) (Millions $) |
-30 |
| Cash Flow (TTM) (Millions $) |
-1 |
| Capital Exp. (TTM) (Millions $) |
1 |
Prosomnus Inc
Prosomnus Inc is a medical technology company specializing in the design and production of oral devices for the treatment of sleep-related breathing disorders, particularly obstructive sleep apnea (OSA). The company's primary product is the Prosomnus Sleep Technologies, a custom-made oral appliance for OSA patients.
The Prosomnus Sleep Technologies aim to provide a comfortable and effective alternative to traditional continuous positive airway pressure (CPAP) therapy. These devices are designed to maintain an open and unobstructed airway by repositioning and stabilizing the jaw during sleep. They are custom-fit to each patient's unique dental anatomy, ensuring optimal comfort and treatment efficacy.
One of the key advantages of the Prosomnus Sleep Technologies is its compact and non-invasive nature. Unlike CPAP machines, which involve wearing a mask and relying on a constant airflow, the oral appliance is discreet and portable, allowing patients to sleep comfortably and freely move during the night. The devices can also be easily adjusted and fine-tuned to the patient's needs, promoting higher compliance and better treatment outcomes.
Additionally, Prosomnus Inc prioritizes research and innovation. They collaborate with leading sleep specialists and institutions to continually improve their products and contribute to the advancement of sleep-related breathing disorder treatments. The company's commitment to evidence-based practice and clinical outcomes ensures that their devices are safe, effective, and based on the latest scientific knowledge.
Overall, Prosomnus Inc offers a promising solution for individuals suffering from sleep-related breathing disorders. Their custom-made oral devices provide a comfortable and effective treatment option, improving patients' quality of sleep and overall well-being.
Company Address: 5675 Gibraltar Drive Pleasanton 94588 CA
Company Phone Number: 537-5337 Stock Exchange / Ticker: NASDAQ OSA
|
3.07% 